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Abstract 
Although the aetiology of many neurodegenerative diseases differ, they all share a 
common feature in that they result in neural cell death. Neural precursor cells (NPCs) of the 
adult brain are thought to be capable of regenerating the injured brain by replacing cells that are 
injured or have died. NPCs ofthe adult brain are maintained in a balance of proliferation and 
death; however, little is known about the molecular mechanisms that regulate these processes. As 
Mel- I is a critical survival factor for NPCs in the embryonic brain, I questioned whether Mcl-1 
regulates the survival of adult NPCs. To determine whether Mcl-1 is expressed in adult NPCs, I 
used BrdU to identify different subpopulations ofNPCs based on their proliferation kinetics. In 
doing so, I demonstrated that Mel- I is expressed in both the neural stem and neural progenitor 
populations ofthe adult subventricular zone (SVZ). To determine the role ofMcl-1 in adult 
NPC's, I used the Crellox conditional knockout system to conditionally knock out Mcl-1 in adult 
NPCs. To assess Mcl-1 loss-of-function in NPCs in vitro, l first drove Cre recombinase off the 
chicken P-actin promoter and stained the cultures with Nestin. Secondly, I drove Cre 
recombinase off the Nestin promoter (NesCre), which resulted in Cre expression specifically in 
NPCs. In both experiments, Mcl-1 loss-of-function resulted in a 2-fold increase in apoptosis in 
Cre transfected Mcl-1 rtr NPCs. When Mcl-1 loss-of-function was characterized in vivo, there was 
a 2-fold increase in apoptosis in Cre transfected Mcl-1 rtr NPCs. Finally, Mcl-1 gain-of-function 
was assessed, in vitro, which resulted in a 2-fold reduction of apoptosis in Nestin + NPCs. 
Collectively, these data demonstrate that Mcl-1 is a prosurvival factor in adult NPCs. Therefore, 
Mcl-1 gain-of-function may lead to an expansion of the adult NPCs, which could offer a putative 
therapy for neurodegenerative conditions and ultimately facilitate neural regeneration. 
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Chapter 1 
Introduction 
1.1 Adult Neural Stem Cells and Neurodegenerative Disease 
Although the etiology of many central nervous system (CNS) diseases such as stroke, 
Alzheimer s di ea e and Parkinson's disease differ, they all share a common feature in that they 
result in neural cell death, which leads to functional impairment. Various cell replacement 
therapies have been attempted including transplant therapies; however, cell death remains the 
biggest drawback to exogenous cell therapies. With the discovery of endogenous neural stem 
cells (NSCs) in the adult mammalian brain (Reynolds & Weiss, 1992), there has been a lot of 
excitement surrounding the possibility of therapeutically manipulating the e populations in a 
variety of neurodegenerative conditions. For instance, several stud ies have shown a transient 
increase in cellular proliferation in the subventricular zone (SVZ) after ischemic stroke 
(Arvidsson et a!., 2002; Jin eta!., 2001 ). However, this response from the SVZ seems to be 
insufficient as only a mall number of cells differentiate into neurons. By identifying the 
molecular mechanism regulating proli feration, survival migration, differentiation and 
integration, it may be possible to optimize neurogene is and ultimately regeneration after neural 
degeneration or injury. This thesis focuses on the survival of neural precursor cells (NPCs) and 
puts forward the hypothesis that the expression levels of a specific protein, myeloid cell 
leukemia I (Mcl-1 ), dictates the sensitivity ofNP s to apoptosis within the adult mammalian 
brain. 
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1.2 Neural Precursor Cells of the Adult Mammalian Brain 
In 1992, Reynolds and Weiss (1992) used the two defining properties of all stem cells, 
self-renewal and potentiality, to show that cells found within the SVZ of3- to 18-month old 
adult mice are mitotic and have the capacity to differentiate into neural lineages in vitro, thus 
providing empirical evidence for the existence of adult NSCs. Subsequent studies have found 
that adult neurogenesis occurs within the SVZ and the hippocampal subgranular zone (SGZ). 
Within the SVZ there are several subpopulations, which are collectively known as NPCs (Figure 
I). The most primitive cell types are the neural stem cells (type B cells), which are defined as 
having long-term, self-renewing capacity and multipotentiality, meaning that they can 
differentiate into all three neural lineages, which include neurons, astrocytes and 
oligodendrocytes (Morshead et. al, 1998). The more restricted type C transit amplifying cells 
(TACs) have lost their self-renewal capacity and are restricted to a single neural cell lineage 
(Morshead et. al, 1994). These cells give rise to the tangentially migrating neuroblasts (type A 
cells) that migrate to the olfactory bulb via the rostral migratory stream and differentiate into 
both granule and periglomerular inhibitory neurons (Doetsch, 2003). Table I provides a list of 
phenotypic markers that will be used to identify these cell types in our work. 
The type B, NSCs persist in the adult mammalian brain largely due to their specialized 
microenvironments or niches that support their lifelong self-renewal and multipotential 
capabilities. As stated above, one ofthe main neurogenic niches includes the SVZ (Figure 1). 
This area consists of a thin layer of dividing cells that is separated from the cerebrospinal fluid 
by a layer of multi-ciliated ependymal cells. This dividing layer contains the type B cells, which 
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have been identified as astrocytes based on their ultrastructural features, phenotypic markers as 
well as electrophysiological properties (Doetsch eta/. , 1999). Although these SYZ astrocytes 
have the characteristics of multi potent stem cells both in vitro and in vivo, there is some debate 
as to whether the SGZ neurogenic niche contains neural stem cells or only committed neurogenic 
precursors (Seaberg & van der Kooy, 2002). Therefore, this thesis will focus on the SYZ PC s 
from this point unless otherwise stated. 
Table 1: Marker expression for the different stages of neural cell differentiation in the 
adult brain. Modified from Okano et al., 2007 
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Figure 1. Cell Types of the Adult Subventricular Zone. The SVZ (orange) is adjacent to the 
lateral ventricles and is lined with multi-cil iated ependymal cells (grey). Type B SVZ astrocytes 
(blue) are stem cells that g ive rise to migrating neuroblasts (A, red) destined for the olfactory 
bulb via the trans it-amplify ing type C cells (green). (Adapted from Riquelme et a!., 2008). 
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1.2.1 Survival and Proliferation of Adult Neural Precursor Cells 
The NPCs found within the adult SYZ exist in equilibrium, such that new cells are 
constantly being produced while cell death is also occurring. In a defining study Morshead and 
van der Kooy ( 1992) used the thymidine analog 5-Bromo-2-deoxyuridine (BrdU) to demonstrate 
that the majority of mitotically active cells ofthe adult subependyma are the type C and type A 
neural progenitors, which collectively have a cell cycle time of approximately 12.7 hours. 
Furthermore, this study suggests that for every neural progenitor cell division, I progeny dies. In 
a subsequent study, Morshead et al. , ( 1994) demonstrated that when the neural progenitors of the 
subependyma are depleted using high doses of tritiated thymidine eH-thy) the much smaller, 
more quiescent NSCs will repopulate the neural progenitor population by temporarily shortening 
their cell cycle time. Normally, the quiescent NSC population has a cell cycle time of roughly 28 
days and constitutes less than I% of the proliferating subependyma population, in vivo (Craig et 
al., 1994; Morshead eta!. , 1994). Whether there is an endogenous level of cell death occurring in 
the NSC population has yet to be determined. However, for every type C division, one progeny 
undergoes cell death (Morshead and van der Kooy, 1992). 
The NPCs of the adult SYZ can also be isolated and grown to form clonal neurospheres 
in vitro when epidermal growth factor (EGF) is added to serum free media (Reynolds and Weiss, 
1992; Morshead et al. , 1994). Cells that are derived from neurospheres are multipotent and self-
renew, thus meeting the criteria of type B neural stem cells. On this basis, it had been assumed 
that only the quiescent neural stem cells were capable of producing neurospheres (Morshead et 
a!., 1994) and as a result, many used the neurosphere assay to assess how various manipulations 
to NSCs affected these cardinal properties of neural stem cells. However, Doetsch eta!. , (2002) 
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seriously challenged the assumption that type 8 NSCs were the primary neurosphere forming 
cells when they showed that the majority of EGF-responsive cells appear to be Dlx2+ neural 
progenitors. The expression of Dlx2+ is indicative that the neural progenitor cells have begun the 
differentiation process toward inhibitory neurons destined for the olfactory bulb (Panganiban and 
Rubenstein, 2002), therefore the demonstration that 01x2+ cells are capable of returning to a 
proliferating, sphere forming stem cell underscores the plasticity within the NPC population. 
Although we have known since the early 1990' s that roughly half of the progeny of type 
C cell divisions die in the adult brain, little is known about the molecular mechanisms that result 
in such a high rate of cell death. As the expansion of adult SVZ NPCs is hypothesized to be a 
putative therapy for a variety of neurodegenerative diseases, understanding how endogenous cell 
death of adult NPCs occurs is of huge significance. As apoptosis regulates the size of the 
embryonic NPC population (Kuida, eta!., 1998; Woo, et al. , 1998), this thesis focussed on 
identifying a potent anti-apoptotic factor that is expressed in adult NPCs, which could be used to 
expand the NPC population and provide the injured brain with an enhanced regenerative 
capacity. 
1.3 Regulation of Adult Neural Precursor Cells 
1.3.1 Apoptosis 
Apoptosis was a term first used by Kerr et al., (1972) to describe an energy dependent 
form of cell death that is characterized by DNA fragmentation, nuclear condensation and 
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membrane changes without harming neighboring cells. The two major protein families that 
regulate apoptosis are the caspase family ofproteases and the 8 cell lymphoma (Bcl-2) family. 
1.3.1.1 Caspase Family of Proteases 
There have been fourteen caspases identified and all share common characteristics 
including being aspartate-specific cysteine proteases, having the conserved pentapeptide active 
site "QACXG" (X can be R, Q or D) (Fan eta!., 2005). Furthermore, the caspase family is 
divided into 3 subfamil ies based on amino acid homology: the initiator caspases, which include 
caspase 9, the apoptosis executioners including caspase 3 and 7, and the inflammatory mediators. 
With the exception ofcaspase 14, a ll ofthe caspases are translated as inactive zymogens and are 
regulated at the posttranslationallevel. The initiator caspases contain domains such as the 
caspase recruitment domain (CARD) that enable these proteins to interact with other molecules 
such as apoptotic protease activation factor-1 (Apaf-1 ), which then cleaves the executioner 
proteins (Fan eta/., 2005). Once activated the executioner proteins begin cleaving cellular 
proteins resulting in the morphological changes that are characteristic of apoptosis such as 
plasma membrane blebbing and nuclear condensation (Fan eta/. , 2005). 
There are a variety of caspase fami ly members involved in both developmental apoptosis 
and apoptosis that occurs after acute injury or in CNS degeneration. For instance, embryonic 
NPCs from either caspase 9 or caspase 3 null mice fail to undergo normal developmental 
apoptos is (Kuida, eta/., 1998; Woo, et al., 1998). This results in an increased number of 
surviving NPCs and differentiated cells causing an expanded ventricular zone and cortex, which 
ultimately leads to lethality at the perinatal period (Kuida, eta!., 1998; Woo, eta/. , 1998). 
Furthermore, a variety of injury models of the adult CNS including spinal cord injury, ischemia 
and traumatic brain injury, have demonstrated that significant cell loss occurs through the 
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activation of active caspase-3 and ultimately apoptosis (Springer, 2002). In these models, 
neurons, glia and newly born cells that have migrated from the NSC niches are vulnerable to 
apoptosis (Springer, 2002). Finally, caspase 3, 6 and 8 activity has been demonstrated in both 
neurons and glia of Alzheimer's disease models (Zhang et al., 2000). In all models of 
Alzheimer's disease that identified apoptosis as a contributing factor to degeneration, the 
apoptotic cascade converged on the activation of caspase 3 (Gervais eta!., 1999). Collectively, 
these data demonstrate that active caspase 3 is the major executioner caspa e for CNS apoptosis. 
1.3.1.2 Bc/-2 Family 
The Bcl-2 family is composed of 12 core proteins that contain at least one of the Bcl-2 
homology domains (BH domains) (Chipuk et al., 20 I 0). As described in Figure 2, proteins 
within the Bcl-2 family are functionally divided into three groups based on the presence of the 
four BH domains. The anti-apoptotic proteins contain all four BH domains and function to 
inhibit the oligomerization of the Bax and Bak. The pro-apoptotic proteins are functionally 
subdivided into two groups: the multidomain effector proteins and the BH3-only proteins. The 
multidomain, pro-apoptotic proteins, Bax and Bak, contain BH1-3 domains and activate the 
mitochondrion-mediated pathway of apoptosis after an apoptotic signal has been given. The 
second major class of pro-apoptotic proteins is the BH-3 only proteins and this group is further 
subdivided based on their ability to interact with the anti-apoptotic Bcl-2 proteins, or both the 
anti-apoptotic and multidomain effector proteins. The sensitizer BH-3 only proteins only interact 
with the anti-apoptotic proteins and the current theory suggests that they displace the activator 
proteins, which are then free to facilitate the oligomerization ofBak and Bax, which leads to 
mitochondrial permeablization and ultimately apoptosis (Chipuk eta/., 20 I 0). 
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Within the CNS, Bcl-2 expression peaks from E I 1- 15 in the mou e brain and then begins 
to decline with little staining occurring at birth (Krajew ka et al., 2002). Expression of Bcl-xL, 
another Bcl-2 anti-apoptotic protein, peak in the neural population during the formation ofthe 
neural tube and continues to stay high through birth only to decline about I week after birth 
(Krajewska et a /., 2002). With regard to the multidomain pro-apoptotic Bcl-2 proteins, it is 
known that Bax and Bak are both expressed in the proliferative areas of the brain, as concomitant 
knock out (KO) of these proteins results in hypercellularity (Lindsten et a /., 2005). Although 
there has been ome evidence of the BH-3 only protein Bid in the developing N (Krajewska et 
al., 2002), little is known about the expression and/or function of other BH-3 protein with in 
either the proliferative zone of either embryonic or adult brain. Furthermore, the molecular 
mechanisms that regulate cell death in the adult NPC population have yet to be identified, despite 
the fact that this could optimize the therapeutic potential of this population. 
1.3.1.3 The Mitochondrial- Mediated Apoptotic Pathway 
Figure 3 provide a summary of the molecular mechanisms involved in mi tochondrial-
mediated apoptosis. Multiple apoptotic signals such as endoplasmic reticulum stre s (ER stres ), 
trophic factor withdrawal and UV radiation have the capacity to induce apopto i by causing 
BH-3 only proteins to catalyze Bax and Bak homo-oligomerization, which ultimately leads to the 
permeablization of the outer mitochondrial membrane (OMM). While it is knm n that Bax and 
Bak are the proteins that homo-oligomerize to create the pores within the OMM, there have been 
several key question surrounding the mechanism by which homo-oligomerization of these 
proteins occurs. In the healthy state, both Bax and Bak exist as monomer with Bax being 
unbound in the cytosol and Bak existing as an OMM tran membrane protein. The Bak monomer 
i in erted into the OMM because its C-terrninal a9 helix does not interact with the -terminal 
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a. I helix, which is the case for the Bax monomer (Suzuki et al., 2000). It is known that certain 
BH-3 only molecules interact with Bak and Bax to induce homo-oligomerization (Cheng et al., 
2001) but the precise mechanism by which this occurs was not established until recently. In a 
landmark study, Kim et al. , (2009) showed that under ER stress, the BH-3 only activator proteins 
tBid, Bim and PUMA bind to theN-terminal a. I helix ofBax, which releases its C-terminal a.9 
helix enabling the Bax monomer to insert into the OMM. Once inserted into the OMM, the 
activator proteins can continue to interact with N-tenninal of both Bax and Bak to induce the 
higher-ordered tetramers that create the transmembrane channel known as the mitochondrial pore 
that allows cytochrome c to be released from the mitochondria (Saito et al., 2000). 
Once cytochrome c is released into the cytosol, it binds to Apaf-1 in an energy dependent 
manner (Li eta/. , 1997). Other proteins such as second mitochondria-derived activator of 
caspase (SMAC) are released through mitochondrial pore, which interfere with the ability of 
proteins such as X chromosome-linked inhibitor of apoptosis protein (XIAP) that block the 
activation of caspase 3, 7 and 9. Once activated, caspase 9 can interact with cytochrome c and 
Apaf-1 to form a complex known as an apoptosome (Rodriguez & Lazebnik, 1999), which is 
capable of cleaving the effectors caspase 3 and caspase 7. Once activated, these proteins begin 
cleaving cellular proteins ultimately resulting in morphological change that are characteristic of 
apoptosis such as plasma membrane blebbing and nuclear condensation (Fan et al. , 2005). 
The importance of cytochrome c in the developing central nervous system was 
underscored when Hao eta/., (2005) created a knock-in mouse that expressed a mutant 
cytochrome c protein capable of functioning in oxidative phosphorylation but defunct in its 
apoptotic role. This resulted in an overexpansion in the proliferating ventricular zone a well as 
an overexpansion ofthe cortex and midbrain by E14.5. Similar results were found in Apaf-1 
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knockouts (Hao et a/. , 2005), which collecti vely underscores the importance of mitochondrial-
mediated apoptosis in regulating the size of the NPC population during development. 
Within the mitochondrial-mediated apoptotic pathway, the in itiation of apoptosis can be 
inhibited if the formation of the mitochondrial pore is prevented (Lindsten eta/. , 2005). Kim et 
at. , (2006) have demonstrated that the key role of the major anti-apoptotic proteins, Bcl-2, Bci-
XL and Mel-t is to sequester and inhibit the Bl-1-3 activator proteins that catalyze the homo-
oligomerization ofBak and Bax. This study went on to show that the role of the remaining Bl-1-3 
only proteins, Bad, Noxa, Bmf and Bik-Blk is to prevent the anti-apoptotic Bcl-2 proteins from 
sequestering the activator Bl-1-3 proteins. More specifica lly, Kim et al., (2006) showed that Bad, 
Bmf and Bik-Blk were all capable of inducing apoptosis by displacing Bid from both Bcl-2 and 
Bel-XL, while Noxa was the only BH-3 protein capable of inducing apoptosis by displacing Bid 
from Mcl-1. 
When comparing the roles of the three major Bcl-2 ant i-apoptotic proteins in the 
developing CNS, Mel-t emerges as a critical survival factor in NPCs during neurogenesis. Loss-
of-function studies have shown that Bcl-2 deficiency results in a loss of sympathetic, motor and 
sensory neurons postnatally (Michaelidis et al., 1996), while Bcl-XL deficiency causes a 
reduction in catecholaminergic neurons (Savitt et a!., 2005) . However, Mel- I is the only anti-
apoptotic family member required for embryonic NPC survival during neurogenesis (Arbour et 
a!., 2008). As Mel-t plays such an important role in the survival of the embryonic NPC 
population, it is foreseeable that Mel- I may play a similar role in the adult NPC population. 
Furthermore, if Mel-t was a survival factor for adult NPCs, it could be an appropriate target 
when addressing the question of how one could decrease the endogenous rate ofapoptosis within 
the adult NPC population. 
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Bcl-2 Protein Family 
Anti-Apoptotic Multidomain BH3-only Proteins 
Proteins Proapoptotic 
Proteins 
BH3-only Sensitizer BH3-only Activator 
Proteins Proetins 
Bcl-2 Bax Bad tBid 
Bcl-xL Bak Noxa Bim 
Mel- I Bmf Puma 
Bik-Bik 
Table 2. Bcl-2 protein family and the various subclasses 
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Figure 2. Bcl-2 protein family classes. A representation of each of the three major classes of 
proteins found within the Bcl-2 fam ily. The anti-apoptic proteins contain all four Bcl-2 
homology (BH) domains whi le the multidomain effector proteins contain BH 1-3 domains. In the 
BH-3 only class, both the sensitizer and activator BH3-only proteins contain just the BH-3 
domain. 
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Bcl-2 Antl-apoptotlc proteins 
BH4 BH3 BHl BH2 a9 Helix 
Multidomain Effector Proteins 
al Helix BH3 BHl BH2 a9 Helix 
• BH-3 only proteins BH3 a9 Helix 
-------~ 
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Figure 3. Mitochondrial mediated apoptosis. In the healthy cell, Bax and Bak exist as 
monomers. Upon an apoptotic stimulus, the sensit izer BH-3 only proteins d isplace the activator 
BH-3 only prote ins from the anti-apoptotic Bcl-2 fam ily mem bers. This a llows the activator BH-
3 only prote ins to induce homo-oligomerization of Bax and/or Bak, which results in OMM 
permeablization releas ing cytochrome c into the cytosol where it interacts with Apaf-1 to form 
the apoptosome. Caspase 9 is activated by the apoptosome, which in turn activates caspase 3. 
Active caspase 3 c leaves cellular proteins resulting in the morpho logical changes that are 
characteristic of apoptosis. 
Apoptotic 
Stimulus 
.... 
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1.3.2 Mcl-1 
The Mel- I protein was first isolated from the ML-1 human myeloid leukemia cell line 
during the differentiation ofmonocytes and macrophages and its gene is located on chromosome 
I q21 (Kozopas eta!. , 1993). The Mel- I gene contains three exons and alternative splicing 
produces mRNA transcripts that either contain or lack exon 2 producing the Mel- I Land Mcl-1 
isoforms, respectively (Bingle et al., 2000). With respect Mel- I L, this isoform contains the C-
terminal transmembrane domain, which allows the protein to be inserted into the OMM. It is 
thought that this is where Mel- I L exerts its anti-apoptotic function by inhibiting the activation of 
Bax/Bak (Bingle et al. , 2000). Focussing on Mel-I s, when exon 2 is excluded, there is a shift in 
the reading frame and the resulting Mcl-1 s protein contains only the BH3 domain, thus this form 
of Mcl-1 is proapoptotic (Bingle et al. , 2000). The shift in reading frame occurs when the cell 
enters into an apoptotic cascade resulting in an upregulation of pro-apoptotoic Mcl- 1 s (Marriot et 
a!., 2005). Furthermore, Mel- I isoform does not contain the C-terminal transmembrane 
domain, which may account for some studies suggesting that Mcl-1 is found in the nucleus ofthe 
cell and in turn, has physiological roles that are distinct from its anti-apoptotic role (Jamil, eta!., 
2005). 
The characterization of Mcl-1 has been minimal compared to other Bcl-2 proteins due to 
the fact the Mel- I germline KOs cannot implant in utero because of trophectoderm defects, 
which results in lethality at the peri-implantation stage (Rinkenberger et al. , 2000). However, we 
do know that Mcl-1 has a relatively short half life of approximately 3 hours (Weng et al., 2005) 
and it is strictly regulated at transcriptional, translational and post-translational levels (Akgul, 
2009). For instance, the signal transducers and activators oftranscription (STATS) family of 
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proteins regulate are capable of regulating survival by targeting the Mel-t promoter at the 
transcriptional level while various microRNAs such as mir-29b can directly inhibit Mel-! mRNA 
translation upon an apoptotic st imulus (lsomoto, eta/. , 2005). This tight regulation also appears 
to be crucial in the prevention of cancer, as Mcl-1 expression is enhanced in a variety of cancers 
including multiple myeloma (Wulleme-Toumi eta/. 2005) and B-cell non-Hodgkin ' s 
lymphomas (Cho-Vega, eta/., 2004). 
Much of the current understanding ofthe role of Mel- I has come about through 
conditional knockout ystems such as the Cre/ lox system. For instance, Opferman et al. , (2003) 
generated a conditional KO of Mel-! to specifical ly assess the function of Mel-t within the 
hematopoietic system. Thei r results demonstrate that Mel-t is essential for the urvival of 
hematopoietic stem cells (Opferman eta!. 2005) and development and survival of the BandT 
cell populations (Opferman eta/. 2003). Furthermore, Mel-! expression i a c ritical surv ival 
factor for hepatocytes, which are the proliferating progenitors required for normal liver 
development and functioning (Hikita eta/. , 2009). 
1.3.2.1 Mel-land the Central Nervous System 
Most of the data surrounding apoptosis of the proliferating populations in the CNS has 
been restricted to the developing brain. Recently, Arbour eta!, (2008) have shown that 
embryonic neural precursors express Mel-! during cortical neurogenesis. When Mel-t loss-of-
function was induced during this time period, there wa an increased level of apoptos is in Nestin-
expressing precursor cells, which ultimately lead to severe deficits in cortical neurogenesis 
(Arbour et al, 2008). Moreover, Arbour eta/, (2008) u ed a conditional KO system to 
demonstrate that Mel-t depletion at embryonic day 8 results in embryonic death by E 16-E 17, 
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which underscores the crucial role that Mel- I plays in the developing bra in. Other studies have 
demonstrated that the anti-apoptotic activity ofNotch I in NPCs can be attributed to Mel-! 
upregulation (Oishi eta/. , 2004). In contrast to embryonic NPCs, Mel-! loss-of-function does not 
directly induce apoptosis in differentiated neurons, but Mel- I deficiency potentiates neuronal cell 
death in an acute DNA damage model of apoptosis (Arbour eta!, 2008), demonstrating that Mcl-
1 does play a pro- urvival role in postmitotic cells of the CNS. 
Currently there is little known about the regulation of apoptosis with in the adult SVZ. 
There is ev idence demonstrating that enhanced trophic factor support (Reynolds & Weiss, 1992; 
Craig et a!., 1996), exercise (van Praag eta/., 1999), cell cycle regulators such as Bmi (He eta!., 
2009) can enhance proliferation within the adult SVZ. However, there has yet to be a potent anti-
apoptotic Bcl-2 family member implicated in the regulation of adul t NPC apoptosis or survival. 
However the function of Mel- ! in adult NPC's has yet to be characterized, which could be a 
reflection of the peri-implantation lethality that exists in germline kockouts of this protein . 
1.4 Summary and Hypothesis 
Many neurodegenerative conditions are most prevalent during adulthood; therefore focus 
has recently been directed towards regenerative strategies within the adult brain. When 
compared to the embryonic brain, the endogenous neural precursor populations of the adult brain 
are quite small and without manipulation offer the damaged brain an insignificant level of 
functional regeneration. One putative therapeutic approached to regeneration of the adult brain is 
to expand the endogenous neural precursor population. When looking for potential genetic 
targets, Mel- I has emerged as a viable cand idate as the Mel- ! conditional KO results in a 
dramatic increase in apoptosis of the embryonic NPCs (Arbour eta!, 2008). Although th is is 
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promising, there has yet to be any evidence that Mcl-1 is even expressed in the adult neural 
precursor population, let alone whether Mcl-1 is a prosurvival factor within this population. 
Therefore, to begin this journey toward improv ing the therapeutic efficiency of the endogenous 
neural precursor population of the adult brain, I put forward the following hypothe is: 
Hypothesis: 
Mcl-1 is a pro-survival factor within the adult neural precursor population of the adult 
mammalian brain. 
1.5 Objectives 
The main objectives of this thesis are as follows: 
I. To demonstrate that Mcl-1 i expressed in proliferating cell of the adult 
mammalian brain; 
2. To demonstrate that Mcl-1 lo -of-function increases endogenou apoptosis of 
adult PCs; 
3. To investigate whether Mcl-1 gain-of-function reduces endogenous apoptosis in 
adult NPC's. 
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Chapter 2 
Materials and Methods 
Mice and Genotyping 
Adult floxed Mcl-1 (Mcl-1 rtr) mice or FVBN wi ld type control mice ranging from 2-6 
months of age were used. Mice were kept on a 12hr light/dark cycle and food/water was 
administered ad libitum. All experiments were approved by the Memorial University of 
Newfoundland 's Internal An imal Care Committee adhering to the Guidelines of the Canadian 
Council on Animal Care. 
Mcl-1 rtr mice were previously generated by Opferman et al., (2003) . To determine the 
genotype of each animal, D A was acquired from tail c lippings and isolation wa completed 
using the REDExtract-N-Amp tissue PCR kit (S igma 029K6262). Once i o lated, the DNA was 
combined with the polymerase chain reaction (PCR) reaction components as outlined in Table 2. 
The PCR reaction (94°C for 6 min; 55°C for I min; 72°C for I min) was then carried out for 30 
cycles. The products of the PCR reaction>.: ere run on a 2% agarose gel containing ethid ium 
bromide (15585-0 II ; Invitrogen), which binds to D A and fluoresces under ultraviolet light. As 
the Mcl- Jwtlwt a lle le (360bp) lacks the two 34bp loxP sites that flank exon I ofthe Mcl-l rtr allele 
( 400bp) (Operferman et a/. 2003), it can be separated from the Mcl-1 rtr allele via e lectrophoresis 
on an agarose gel (Figure 4). Therefore, the two pos ible alleles can be di tinguished according 
to band size as shown in Figure 4 and the genotype of each mouse can be determined. 
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Component Volume/Sample (JlL) 
1 OX Reaction Buffer 5.0 
Primers (2.5f.!M): 
*6Mcl-1 5.0 
**7Mcl-l 5.0 
1.25mM dNTP' s 8.0 
50mM MgCb 1.5 
Taq polymerase 0.5 
Water 22.0 
DNA 3.0 
*6Mcl-1 = 5' GCA GTA CAG GTI CAA GCC GAT G3 ' 
**7Mcl-1 = 5'CTG AGA GTI GTA CCG GAC AA3 ' 
Table 3. Components of Mcl-1 PCR reaction solution 
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Figure 4. Mcl-1 genotypes can be determined through PCR and gel electrophoresis. The 
Mclrtr allele contain two 34-bp loxP sites, which make it larger than the wild type Mcl-1 allele. 
The PCR products of these two alleles are separated by placing them in a 2% agarose gel and 
applying electrophoresis. By doing this, the different alleles will separate and the genotype can 
be determined. 
Mcl-1 Flox 
Mcl-1 W.T. 
00 bp 
60 bp 
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Acquisition of Clonally Derived Neural Precursor Cells 
NPCs were obtained from adult Mcl-1 r;r and wild type control mice (2-6 months old). 
Mice were euthanized with a 0.3ml intraperitoneal (i.p.) injection of Euthanol (2.5mg/kg). NPCs 
were acquired as depicted in Figure 5. Access to the SVZ was acquired by separating the 
hemispheres along the longitudinal fissure and removing the overlying cortex. The exposed SVZ 
was then dissected out, cut up and dissociated by manually triturating in artificial cerebrospinal 
fluid [(2M NaCl (S271-3, Sigma), I M KCl (P333, Sigma), I M MgCb (M2393, Sigma), 155mM 
NaHHC02 (Sigma, S576), 1M glucose (G7528, Sigma), I 08mM CaCb (C7902, Sigma)] and 
incubated at 37°C for 15 min with trypsin enzyme (T4549, Sigma) to chemically digest the 
tissue. The solution was then spun at 5000rpm for 5 min and the pellet was resuspended and 
plated in DMEM/F 12 (911330, Gibco) and the following: 0.0033mol/L D-glucose (G7528, 
Sigma), 0.5% penicillin-streptomycin (15140-122; Invitrogen), 0.5% insulin (1-5500, Sigma), 
0.2% apo-transferrin (T4382, Sigma), 0.002% progesterone (P8783, Sigma), 0.12% putrescine 
(P5780, Sigma), 0.015% selenium (S5290, Sigma), 0.1% fungizone (Gibco; 15290-0 18) and 
0.02% Heparin (H3149, Sigma) supplemented with I% 827 (Invitrogen; 17504-044), 0.1% 
FGF-2 (Sigma; F0291) and 0.02% EGF (Invitrogen; 13247-051) (Tropepe et at., 1997). Neural 
precursor cells (NPCs) were plated at clonal density (I Ocells/f.!l) unless otherwise stated and 
primary neurospheres were grown for plasmid transfection. 
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Figure 5. Acquisition of Clonally Derived Neural Precursor Cells. The SVZ of Mcl-1 flf and 
wild type mice were dissected, then expanded in serum-free media containing FGF-2, EGF and 
heparin. Neurospheres were mechanically dissociated and plated as sing le cells 12- 16hrs before 
transfection. (Modified from Chojnacki et al. , 2009). 
Tissue dissected from 
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Plasmid Constructs 
Cre, Mcl-1 , Ne GFP and NesCre were cloned into the pCIG2 vector (Megason & 
Mcmahon, 2002) in our laboratory at Memorial University of ewfoundland and their maps are 
shown in Appendix A. To a sess Mcl-l loss-of-function, the Cre construct (Tranche eta/., 1999) 
was cloned into the pCIG2 expression vector (Megason & Mcmahon, 2002). To selectively 
target the NPC population, the heat shock protein 68 minimal promoter (Rossant eta!. , 1991) 
linked to the 2nd intron Nestin enhancer element (Kawaguchi eta/., 200 I) wa u ed to drive 
either GFP or Cre expres ion in Nestin expres ing neural precursors. The Mel- I expression 
construct (Rinkenberger eta/. , 2000) was cloned into the pCIG2 vector (Mega on & Mcmahon, 
2002) to assess Mel-t gain-of-function. Protein expre sion ofboth Cre and Mel-t in HEK 293A 
cells was verified by western analysis (Fig, 6 A,B). 
In Vitro Transfection and Immunocytochemistry 
Cells were plated at a density of2 x I 05 cells/ml in eurobasalmedia (Gibco; 2 11 03-049) 
supplemented with 0.25% L-glutamine ( igma; 25030-081 ), 0.1% fungizone (G ibco; 15290-
0 18), 2% 827 (Invitrogen; 17504-044), I% N2 (Sigma; 17502-048), 0.1 %FGF-2 (25~-Lg/ml ; 
Sigma; F0291) 0.02% EGF (Invitrogen; 13247-051 ). 12-16hrs after plating, the cultures were 
transfected with GFP, Mel- I or Cre plasm ids using Lipofectamine Plus reagent (Invitrogen; 
11668-027). After 6-hr , additional media was added such that the cells were at clonal density. 
Cultures were incubated for 24, 36, 48, or 60 hrs and fixed with cold para formaldehyde (PF A, 
pH; Sigma; F8775). 
All GFP positive cells were assessed for apoptosis based on nuclear condensation as 
visualized by Hoech t staining (60~-Lg/ml ; igma· B 1155). To specifically identify P that 
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were transfected with the plasm ids that are driven off of the universal chicken P-actin promoter, 
cultures were immunostained with Nestin antibody (mouse monoclonal, I :200; Millipore 
MAB353). 
In vivo Plasmid Injections and Electroporation 
Plasmid transfection of PCs in vivo was accomplished as described previously 
(Barnabe-Heider et al., 2008). Adult Mcl-1 rtr and wild type control mice were anesthetized using 
isofluorane. The dorsal portion of the head was shaved and the animal was secured in the 
stereotaxic device. Once secured, the shaved portion of the skin was terilized with provoiodine 
olution (Rougier; 00 172944) and the skull was exposed. Both Bregma and Lamda were 
landmarked to ensure that the head was positioned equally in all three axes. Once aligned, the 
injection site was marked with the following coordinates: Anterior-Posterior: 4.0mm from 
bregma; Medial-Lateral: 0.6mm from the midline. After drilling through the skull, the dura was 
pierced to allow the injection needle to go through with ease. The loaded injection needle was 
then secured to the stereotaxic device and lowered to the surface of the brain and measurement 
was taken at the cortical surface. The injection needle was then slowly lowered ventrally by 3-
4mm and the 2j..LL plasmid volume (6-1 Oj..Lg/j..LL) was infused into the lateral ventricle over a 2 
minute period. Within I minute of completion of the injection, electrode gel (Spectra) was 
applied to both ide of the dorsolateral aspects ofthe kull and a 5-pulse current at 200V and a 
duration of 50ms and an interpulse interval of 950ms was passed through the brain. The injection 
needle was then slowly removed from the brain and skin was sutured. 
Mcl-1 & Adult NPCs 35 
BrdU labeling of Proliferating Cells 
5-Bromo-2-deoxyuridine (BrdU, igma; B5002) was used to label the proliferating cells 
of the SVZ. Wild type mice were given an intraperitoneal BrdU injection (IOO~g/g body weight) 
every two hours for I 0 hours. To specifically target the neural progenitor cell , the mice were 
euthanized 30 minutes after the last BrdU injection. To specifically target the slowly dividing 
neural stem cells, animals were allowed to live for 28 days after the last injection. In both group , 
coronal sections were collected beginning at the formation of the corpus callo urn and continuing 
caudally until the third ventricle. Roughly every fifth section was asses ed and quantification 
was measured by calculating the percentage of BrdU positive cells that were al o positive for 
Mcl-1 staining. 
Tissue Processing and Immunohistochemistry 
Adult mice were euthanized and perfu ed with I X phosphate buffer olution (I X PB ) 
fo llowed by cold 4% PFA. Brains were removed and postfixed overnight in 4% PFA and 
cryoprotected incrementally using 12%, 16% and 22% sucrose (Sigma) di solved in I XPBS. 
Brains were then frozen and coronal sections ( 1 4-~m) were collected on Superfrost Plus slides 
(Fisher Scientific) using a freezing cryostat microtome (Microm, HM520). For all subsequent 
BrdU immunostaining, sections were incubated in 2 HCI at 37°C for 30m in followed by a I O-
m in wash in 0.1 M sodium borate (pH 8.0) to denature the D A. Immunohi tochemistry was 
performed with primary antibodies for Mcl-1 ( I :400; Santa Cruz; sc-819), Brd U ( I: I 00; BD 
Biosciences; 347580) and Hoechst (60~g/ml ; Sigma; B 11 55) was used to stain nuclei. 
For the in vivo electroporation study, apoptosis oftransfected cel l (GFP+) was assessed 
at 72hrs after electroporation. Mice were perfused and tissue was processed as described above. 
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Coronal sections were collected beginning at the rostral site oftransfection (i.e. a soon as GFP+ 
cells were present) and apoptosis was assessed via nuclear condensation as visualized by 
Hoechst staining. A minimum of 50 GFP+ cells was assessed per brain in each treatment group 
(NesGFP range: 58-158; NesCre range: 50-200). The percentage of apoptotic cells was 
calculated by dividing the number ofapoptotic GFP+ cells by the total number ofGFP+ cells per 
brain. 
Western blot Analysis 
As shown in Figure 6, western blot analysi was performed on HEK 293A cells to 
demonstrate plasmid expression. To extract the protein, complete immunoprecipitation (IP) 
buffer [25mM Tris-base (Roche, 1070897600 I); 150mM NaCI (Sigma, C7902); I mM CaCb 
(S igma, C7902); I% Triton X-1 00 (Sigma, 93426); I OOj..l.L phenylmethylsulfonyl Floride 
(S igma, P7626); 1 011L OTT (Sigma, 43816)] was added to cell pellets and incubated on ice. 
Samples were mechanically triturated and centrifuged at 2000 rpm for 5 min and the supernatant 
was transferred to a new pre-chilled tube. Protein concentration was determined using the Bio-
Rad protein Assay kit I (500-000 1) and a Thermo cientific Genesys I OUV pectrophotometer 
reading at 595nm absorbance. 
Separating gels and stacking gels were made as shown in Table 4 and 5, respectively. 
30j..l.g of protein was added to 5j..l.L of protein loading buffer [250mM Tris-HCI (Fisher, 89153); 
0.5 OTT; 10% sodium dodecyl sulphate (SDS, 155-25-0 17 Invitrogen); 50% Glycerol (S igma, 
G5516); 0.5% Bromophenol Blue (Fisher, 8392-5)] and topped up to 25 j..l.L with complete IP 
buffer. Protein was denatured by boiling for 5 minutes. After denaturation, I 011L of each protein 
sample and kaleido cope prestained protein standards (Bio-Rad, I 6 I -0324) were loaded into the 
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gel, which was then submerged in running buffer [0.6% Tris-base, 1.1 25% glycine (Bio-Rad, 
16 1-0724 ), 0.1% SDS] and run at II OV for approximately two hours. Protein was then 
transferred to a nitrocellulose membrane (Hybrid-ECL, LRPNK/95/81) by sandwiching the 
nitrocellulose membrane w ith the separating gel. The cassette was then submerged in transfer 
buffer [0.3% Tris-base, 1.1 25% glycine and 20% methanol (S igma, 179337)] and run at 190 
amps for 1.5hrs. Following protein transfer, the membrane was washed in Tween20 phosphate 
buffer solution [(TPBS); 1.42% Na2HP04 (Fisher Scientific, S374-500), 1.38% NaH2P04 
(Fischer Scientific, S399-500), I% NaCI (Fisher Scientific, S27 1 ), 0.1% Tween20 (Sigma, 
P7949)], blocked with 5% blotto (mi lk powder in TPBS) and incubated overnight with primary 
antibodies. The membranes then underwent 3x 15 min washes of 0.5% blotto and were incubated 
with Horseradish peroxidase conjugated to econdary antibodies (I :2000; BioRad; anti-rabbit 
IgG: 1706515, anti-mouse IgG: 1706515) for I hr. After secondary antibody exposure, 
membranes underwent 3, 15 min washes ofTPBS and the peroxidase reaction was then 
catalyzed with chemiluminescence reagent (Western lightning (Nell 00) for I min. Blots were 
blotted and exposed to Fuji Medical X-Ray film (I OONIF) for I-3min and developed on a Mini 
Medical Series developer. Primary antibodies used were as fo llows: Mcl-1 ( I : I 0,000; Rockland 
lmmunochemicals; 600-40 1-394); Cre recombinase (I: I 0,000; Chemicon, MAB3120); and anti-
P-Actin (I :2000; Sigma; A53 16-2) as a loading control. 
Stock Solution Separating gellO% (20ml Final Volume) 
dd water 7.0ml 
O.SM Tris, 1.5M glycine 4.0ml 
10% SDS (RT) 0.8ml 
50% glycerol 2.0ml 
40% acrylamide; 0.25% bisacrylamide 5.0 ml Filtered 
Ammonium persulphate (made fresh) 30mg in 1 ml of dd water 
10% TEMED 0.02ml (TEMED) 
Table 4. Separating gel. 
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Stock Solution Stacking gel14% (lOml Final Volume) 
dd water 4.05ml 
0.5 M Tris-HCI pH 6.8 1.4ml 
10% SDS (RT) 0.4ml 
SO% glycerol l.Oml 
40% acrylamide, 0.25% bisacrylamide 1.25ml FILTERED 
Ammonium persulphate ( made fresh) 2Smg in 1ml of dd water 
10% TEMED 0.01 ml (TEMED) 
Table 5. Stacking gel. 
Microscopy and Statistics 
Immunostained cultures were examined on a Zeiss AxioObserver A. I microscope while 
immunosta ined sections were examined on a Zeiss Axio lmager Z. l microscope. All images were 
taken with a Zeiss AxioCam MRm camera using Zeiss AxioYision 4.8 software. All figures were 
created using Adobe Photoshop CS2. Jf required, manipulations of brightness and contrast were 
made such that all treatment groups received the same adjustments. A ll statistics were completed 
on GraphPad Prism 5 so ftware, including unpaired T-test and both one and two way analys is of 
variance. T ukey' s posthoc analysis was used to determine differences between treatment groups. 
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Figure 6. Western analysis of protein expression. A, Western analys i of protein expression 
from 293A cells that were transfected with a pCIG2 vector (GFP) or pCIG2 vector containing 
Cre recombina e ( re) or untransfected cell (control). 48hrs after transfection, cells were 
collected for Cre protein analysis. B, Western analy is of Mcl-1 protein express ion from 293A 
cells that were transfected with a pCIG2 vector (GFP) or pCfG2 vector containing Mcl-1 (Mcl-1 ) 
or untransfected cells (control). 48hrs after transfection, cells were collected for Mcl-1 protein 
analysis. Blots were reprobed with Actin as a loading control. 
\ 
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Chapter 3 
Results 
Mcl-1 is Expressed in NPCs of the Adult SVZ 
To demonstrate that Mc l-1 is expressed in NPCs of the adult SVZ, I used a cumulative 
BrdU labeling assay that labels cells undergoing S-phase of the cell cycle. By administering a 
BrdU injection every two hours for ten hours and euthanizing the animals 30 minutes after the 
last injection, it is po s ible to label the majority of the TACs ofthe adult VZ and a very few 
neural stem cells (Morshead & van der Kooy, 1992). When the proliferating cells of the SVZ 
were labeled in this manner, approximately 63% of the BrdU cells also expressed Mcl-1 (Fig. 
7 A, B; an average of 225 per brain BrdU positive cells were assessed ; n=3), sugge ting that a 
subpopulation of the tran int amplifying population expresses Mcl-1. 
To specifically assess whether Mcl-1 was expre sed in the quiescent tern cell population 
of the adult SVZ, I took advantage ofthe fact that the cell cycle time ofthi population is 
approximately 28 days (Craig el a!. , 1994· Morshead et al. , 1994) while the cell cycle time of the 
TACs is 12.7 hours (Morshead & van der Kooy, 1992). By using the same BrdU labeling assay 
a above and a llowing the an imals to live for 28 days, the few quiescent stem cell that 
underwent S-pha e during the BrdU assay wi ll be the only cells that retain BrdU in the SVZ. One 
can assume that all the BrdU positive cells remaining in SVZ are the quiescent stem cell 
population because TACs that were initia lly labelled will die, migrate away from the SVZ or 
dilute the BrdU signal out as they continue to divide (Morshead et al., 1994; Craig el al. , 1994). 
When the percentage of BrdU positive cells that were co-labeled with Mcl- 1 was quantified, 
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approximately 52% of the BrdU labeled neural tern cells also expres ed Mel-t (Fig. 78; an 
average of91 per brain BrdU positive cells assessed; n=4 ). Taken together, these results 
demonstrate that Mel-t i expressed in both the TACs and the more quie cent N C population of 
the adult SYZ. 
Mcl-1 Loss-of-Function Increases Apoptosis of Adult NPCs in vitro 
To characterize the function of Me l- t in adult NPCs, I began by using loss-of-function 
strateg ies in vitro. In the first set of experiment , Mel- I loss-of-function was induced by 
transfecting D A expres ion plasmids into YZ-derived cultures from both wi ld type and Mel-
t rtr brains. The pia mids used in this initial study directed either Cre recombinase (Cre) or 
control (GFP) off of the chicken ~-actin promoter which induces robust prote in expression in all 
VZ-derived cell types. Expression of both the GFP and Cre plasmids occurred by 24hrs (Fig. 
8C) and I assessed apopto is on the basis of nuc lear condensation becau e this mea ure of 
apoptosis is less transient compared w ith other measurements of apoptos i , such a active 
caspase 3. T his resulted in a significant degree of chromatin condensation in Mel-t rtr cultures 
that were transfected with the Cre plasmid . Indeed, when this measure of apoptosis in Cre 
transfected Mel- I rtr cultures was compared to all controls, there was a 2 fold increase in 
apoptosis (Fig.8C; Wt.GFP vs. Mel- I rtrCre, Wt.Cre vs. Mel-t rtrCre, Mel-t rtrGFP vs. Mel- I rtrc re: 
p<O.OO I ; n=3). This effect was sustained at all time points measured (Fig. 8 ) indicating that a 
higher rate of apoptosis wa sustained for at least 60 hrs in Cre transfected Mel- I rtr cells when 
compared to controls. 
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Figure 7. Mcl-1 is expressed in proliferating cells of the adult subventricular zone, in vivo. 
FVBN mice received a BrdU injection (I OOJlg/g) every 2hrs for I Ohrs and were euthanized at 
30min. or 4 weeks after the last injection. A, Representative photomicrographs of proliferating 
neural precursor cells labelled with antibodies against Mcl-1 (green) and BrdU (red). B, 
Quantification of the percentage of BrdU positive cells that are also Mcl-1 positive. 
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As previou tudies have demonstrated that embryonic NPCs undergo apoptosis after 
Mcl-l is knocked out (Arbour et al., 2008), a Nestin antibody was applied to these cultures to 
pecifically label adult NPCs. When apoptosis was as essed at 36hrs, there wa at lea t a 2 fold 
increase in apoptosis in Cre transfected Mcl-1 rtr cell compared to control groups (Fig. 8A,B,D· 
Wt.GFP vs. Mcl-1 rtrcre: p<.OS; Wt.Cre vs. Mcl-1 rtr re: p<.O 1; Mcl-1 rtrGFP vs. Mcl-1 rtrcre 
p<O.OS; n=3). This effect was also seen at 60 hrs. (Fig. 80; Wt.GFP vs. Mcl-1 rtrcre: p<O.OS ; 
Wt.Cre vs. Mcl-1 rtrcre: p<.OS; Mcl-1 rtrGFP vs. Mcl-1 rtrcre p<O.OS; n=3). Overall, this indicates 
that Mcl-1 is a pro- urvival factor in Nestin-po itive PCs, in vitro. 
To underscore the fact that Mcl-1 loss-of-function increases apopto is in adult PCs in 
vitro, I did another set of experiments using DNA expression plasm ids that directed either Cre or 
GFP off of the Nestin enhancer promoter. This promoter is only functional in Nest in expressing 
NPCs (Lothian eta/. , 1999). Therefore, only NPC will express Cre (NesCre) or GFP (NesGFP) 
proteins. As in our previous experiment, there was a 2 fold increase in apopto is in Cre 
transfected Mcl-1 rtr PCs at 36 hrs (Fig.9A,B C; Wt. esGFP vs. Mcl- 1 rtf es re: p<O.OO I; 
Wt.NesCre vs. Mcl-1 rtrNesCre: p<.O 1; Mcl-1 rtrNesGFP vs. Mcl-1 rtrNe Cre p<O.OS n=3). 
Furthermore, this effect was also observed at 60 hrs (Fig.9C; Wt.NesGFP vs. Mcl-1 flfNesCre: 
p<O.O I; Wt.NesCre vs. Mcl-1 rtr e Cre: p<O.O I ; Mcl-1 rtrNesGFP vs. Mcl-1 rtr esCre p<O.OS; 
n=3). Overall, these data, combined with the data using the chicken P-actin promoter show that 
Mcl-1 is a pro-survival factor of adult NPCs, in vitro. 
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Figure 8. Mel-t loss-of-function results in increased apoptosis ofNestin-positive adult 
NPCs, in vitro. A, Representative photomicrographs of wi ld type (top panel) and Mcl- 1 rtr 
(bottom panel) Nestin-positive NPCs transfected with expression plasmid conta ining GFP. B, 
Representative photomicrographs of wild type (top panel) and Mcl-1 rtr (bottom panel) Nestin-
positive NPCs transfected with expression plasmids containing Cre recombinase. Cells were 
plated at 2 x I 05cells/mL and transfected with GFP or Cre expression plasm ids 12hrs after 
plating. C , Quantification of the percentage of transfected cells that are apoptotic. Apoptosis was 
assessed by nuclear condensation visualized by Hoechst staining at 24, 36, 48 and 60hrs after 
tran fection. D, Percentage of Nestin-positive transfected cells that are apoptotic. Cells were 
stained with primary antibody against Nestin at 36 and 60hrs after transfection. Results are 
expressed as mean ± SEM (n=3). *p<O .05, **p<O.OO I 
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Figure 9. Mcl-lloss-of-function results in increased apoptosis ofSVZ-derived NPCs, in 
vitro. A, Representative photomicrographs of wild type (top panel) and Mel- I rtf (bottom panel) 
NPCs transfected with expression plasmids containing NesGFP. B, Representative 
photomicrographs of wild type (top panel) and Mel-! f/f (bottom panel) NPCs transfected with 
expression plasm ids containing NesCre. Cells were plated at 2 xI 05cells/mL and transfected with 
NesGFP or NesCre expression plasmids 12hrs after plating. C, Quantification ofthe percentage 
oftransfected cells that are apoptotic. Apoptosis was assessed by nuclear condensation at 24, 36, 
48 and 60hrs after transfection. Results are expressed as mean± SEM (n=3). *p<O .05 
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Mcl-1 Loss-of-Function Increases Apoptosis of Adult NPCs in vivo 
As I have shown that Mcl-1 loss-of-function results in increased apoptosis of adult NPCs 
in vitro, I next addressed the question of whether Mcl-1 loss-of-function also affects the survival 
ofNPCs, in vivo. To address this question, l used in vivo electroporation (Barnabe-Heider eta!., 
2008) to transfect either NesGFP or NesCre into NPCs in the SVZ of adult wildtype or Mcl-1 rtr. 
By 72 hrs after transfection, there was robust expression of both plasm ids in all genotypes 
(Fig. I OA B). When chromatin condensation was assessed at 72 hrs, Mcl-1 rtr NPCs transfected 
with NesCre had a significantly higher rate of apoptosis when compared to controls (Fig. I OC; 
Wt. NesGFP vs. Mcl-1 rtrNesCre, Wt. NesCre vs. Mcl-1 rtrNesCre: p<O.O I; Mcl-1 rtrNesGFP vs. 
Mcl-1 flfNesCre p<0.05; n=3). These results support the in vitro findings demonstrating that Mcl-
1 is a potent prosurvival factor for NPCs in vivo. 
Mcl-1 Gain-of-Function Decreases Apoptosis in Adult NPCs in vitro 
To assess whether Mel- I gain-of-function is sufficient to reduce apoptosis in the adult 
neural precursor population in vitro, I performed gain-of-function experiments by overexpressing 
Mcl-1 in adult SVZ-derived cultures. As in our loss-of-function studies, expression of both 
control and Mcl-1 plasmids had occurred by 24 hrs. When apoptosis was assessed by nuclear 
condensation, Mcl-1 overexpression resulted in roughly a 2-fold decrease in apoptosis at 24 hrs 
(Wt. GFP vs. Wt. Mcl-1: p<O.O 1; n=3). This was sustained for 60-hrs after transfection 
(Fig. II A). As I saw a significant increase in apoptosis specifically in neural precursor cells in 
the Mcl-1 loss-of-function studies (Figs. 8,9, I 0), I questioned whether overexpressing Mcl-1 in 
adult SVZ-derived NPCs would decrease the endogenous rate of apoptosis. As in our loss-of-
function studies, the cultures were labeled with the NPC marker Nestin and assessed for 
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apoptosis based on nuclear condensation. When apoptosis was assessed at 36hrs, the level of 
apoptosis did not differ between Mcl-1 overexpression (Fig. 11 B). However, when the level of 
apoptosis was assessed in Nestin positive NPCs at 60hrs, there was a significant reduction in 
apoptosis in Mcl-1 transfected cells (Fig.l1 B; Wt. GFP vs. Wt. Mcl-1 : p<0.01; n=3). These data 
demonstrate that Mcl-1 gain-of-function in NPCs leads to an overall reduction in endogenous 
apoptosis, in vitro. 
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Figure 10. Mcl-lloss-of-function results in increased apoptosis in adult NPCs in vivo. 
esGFP or esCre pia mids were e lectroporated into the rostral lateral ventricle and apoptosis 
was assessed at 72hr . A, Representative photomicrographs of GFP+ cell from coronal wild type 
(top panel) and Mcl-1 flf (bottom panel) brains that were transfected with esGFP. B, 
Representative photomicrographs ofGFP+ cells from coronal sections of wild type (top panel) 
and Mcl-1 rtr (bottom panel) brains that were transfected with NesCre. C, Quantification of the 
percentage of apoptotic wi ld type and Mcl-1 f/ f cell that were transfected with NesG FP or 
esCre in vivo. Transfected GFP positive apoptotic cells were identified by nuclear condensation 
a visualized by Hoech t taining. Results are expressed as the mean ± EM (n=3). *p<0.05 
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Figure 11. Mcl-1 gain-of-function results in decreased apoptosis ofSVZ-derived cultures 
and Nestin-positive adult NPCs in vitro. Cells were plated at 2 xi 05cells/mL and transfected 
with GFP and Mcl-1 expression plasmids 6hrs after plating. A, Quantification of the percentage 
oftransfected cells that are apoptotic. Apoptosis was assessed by nuclear condensation as 
visualized by Hoechst staining at 24, 36, 48 and 60hrs. B, Quantification of the percentage of 
Nestin-positive transfected cells that are apoptotic. Cells were stained with primary antibody 
against Nestin and apoptosis assessed based on nuclear condensation as visualized by Hoechst 
staining at 36 and 60hrs. Results are expressed mean± SEM (n=3). *p<0.05, *p<O.OO I 
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Chapter 4 
Discussion 
Mcl-1 is Expressed in NPCs of the Adult SVZ 
Our initial Mcl-1 co-labeling studies demonstrate that Mcl-1 is expressed in both the 
neural stem cell and neural progenitor populations, in vivo. This is the first time that a Bcl-2 
prosurvival protein has been found to be expressed within the adult neural precursor population. 
The other major Bcl-2 prosurvival proteins, Bcl-2 and Bcl-XL, are expressed at specific times 
during CNS development but the expression of both ofthese proteins significantly declines by 
the first week of postnatal life (Lindsten et al., 2005). Moreover, the fact that Mcl-1 is the only 
Bcl-2 prosurvival factor expressed in NPCs from the early stages ofCNS development (Arbour 
eta/., 2008) into adulthood provides a huge opportunity to manipulate NPC apoptosis in both 
developmental conditions as well as the neurodegenerative diseases that are seen in adulthood. 
In addressing whether Mel- I is expressed in adult NSCs, the animals were euthanized at 
0.5hrs and 28 days after BrdU labeling, which specifical ly labels the neural progenitor and neural 
stem cel l populations, respectively (Morshead & van der Kooy 1992; Craig et al. , 1994). 
Roughly half of BrdU positive cells seen in both populations were co-labeled with Mcl-1 , which 
could suggest that the NPC population is heterogenous with some cells having a requirement for 
Mcl-1 whi le others do not. This is supported by the fact that not all embryonic PCs require 
Mcl-1 for survival (Arbour et al., 2008). Furthermore, Barraud et al. , (2005) a lso suggested that 
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the NPC population i heterogenous by creating a Sox 1-GFP transgenic mouse and using 
fluorescence-activated cell sorting (F ACS) to demonstrate that there are region specific 
morphological and potentiation differences within the ox 1-GFP population. 
Another explanation as to why only half of the PC population are Mcl-1 + may relate to 
the level of cell death that occurs endogenously within this population. ince I progeny will die 
for every neural progenitor division (Morshead & van der Kooy, 1992) the proportion ofNPCs 
that do not expres Mcl-1 may be those cells destined to die. As there is a lack of cell specific 
markers for the different PC subpopulations, one could F ACS sort NP based on Mcl-1 
expression. Ifthi technique did separate the PC subpopulations, then it would support that 
there is a heterogenous population. Furthermore, one could then carry out characterization 
studies for self-renewal, proliferation kinetics and survival to assess potential differences 
between the subpopulation . These studies may provide a significant contribution to our 
understanding of the adult population. Investigations into Mcl-1 ' s function in y terns that have 
the ability to isolate stem and progenitor cells have demonstrated distinct roles for Mel- I in the 
different subpopulations. For instance, Opferman eta/., (2005) demonstrated that conditional 
deletion of Mcl-1 within the Hematopoietic system specifically kills the hematopoietic stem 
cells. If a similar type of specificity was found within the adult NPC population, it could have 
dramatically different impacts and as a result, the strategies that would be developed to use Mel-
t in a regenerative capacity would also differ. 
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Mel-I Loss-of-Function Increases Apoptosis of Adult NPCs both in vitro and in vivo 
Collectively the in vitro and in vivo Mcl-1 loss-of-function experiments demonstrate that 
Mcl-1 is a survival factor in adult NPCs of the SVZ. There have been several studies 
demonstrating increased levels of apoptosis in NPCs cell lines (Walls eta/., 2009) or primary 
NPCs in vitro (Hung & Porter, 2009); however, all of these studies use exogenous initiators of 
apoptosis such as nitric oxide (Hung & Porter, 2009) and hypoxia (Walls et al., 2009). As these 
initiators of apoptosis are present in a variety of disease states, these studies were completed in 
order to characterize the pathophysiology ofNPCs during CNS injury. However, compounds 
such as nitric oxide or a hypoxic state are not present in the healthy brain and therefore, these 
studies do not provide any insight into how adult NPC apoptosis occurs within the healthy brain. 
Having an understanding of the molecular mechanisms that regulate adult NPC apoptosis in the 
healthy brain may provide strategies that facilitate regeneration. This thesis demonstrates that 
Mcl-1 is not only expressed within the adult NPC population but that Mcl-1 loss-of-function 
increases NPC apoptosis without any exogenous apoptotic initiator. This demonstrates that Mcl-
1 is key regulator of adult NPC apoptosis in the healthy brain. 
The Mcl-1 loss-of-function studies presented here are the first experiments to 
demonstrate that an anti-apoptotic protein of the Bcl-2 family has a pro-survival effect on the 
adult NPC population. Since Mcl-1 loss-of-function increases PC apoptosis both in vitro and in 
vivo and Mcl-1 gain-of-function inhibits the endogenous apoptosis in adult NPCs it can be 
suggested that Mcl-1 gain-of-function could possibly provide a protective strategy against NPC 
apoptosis and ultimately facilitate regeneration. 
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Mcl-1 Gain-of-Function Decreases Apoptosis in Adult NPCs in vitro 
The Mel-t gain-of-function experiment uses the wild type form of Mel-t and 
demonstrates that enhancing Mel-t expression in adult NPCs in vitro decreases the endogenous 
rate of apoptosis that is seen within this population. Although this suggests that Mcl-1 gain-of-
function could potentially lead to an expansion of the adult NPC population, unpublished data 
from the Vanderluit laboratory suggest that Mel-t gain-of-function affects the proliferation 
kinetics of embryonic NPC by causing the cells to exit the cell cycle. In spite ofthis, Mel-t 
gain-of-function may have a different effect of the adult NPC population, therefore the risk of 
tumorigenesis is still present. As such, studies ofhow Mel-t gain-of-function affects the 
proliferation kinetics of adult NPCs are currently being conducted within the Vanderluit 
laboratory. However, independent of its affect on cell proliferation, the ability of Mel- I to reduce 
apoptosis in adult NPCs has major implications for adult regeneration . For instance, one of the 
current challenges in stroke regeneration is the fact the NPCs that migrate to the site of injury 
and differentiate ultimately undergo apoptosis (Kernie & Parent, 2009). Therefore, by using a 
Mel-t gain-of-function strategy in conjunction with other regenerative strategies such as trophic 
factor administration (Reynolds & Weiss, 1992; Craig eta!. , 1996), it may be possible to inhibit 
apoptosis in this situation while also circumventing the issue of tumorigenesis that exist with 
many prosurvival proteins. 
A variety of mechanisms have been shown to expand the NPC population both in vitro 
and in vivo. Studies have demonstrated that enhanced trophic factor support such as EGF can 
expand the NPC population both in vitro and in vivo (Reynolds & Weiss, 1992; Craig eta!. , 
1996). Fittingly, exogenous stimuli such as exercise, which are capable of enhancing trophic 
factor production in the stem cell niches have been hown to increase proliferation ofthe NPC 
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population (van Praag eta/. , 1999). Other studies have shown that particular cell cycle 
regulators such as PCNA, the C ip/Kip family and p53 (Bertand & Hermanson. 20 I 0) have the 
potential to alter proliferation within adult NPCs (He eta/., 2009), while inactivation of cell 
cycle inhibitors such as the p 161nk4a and p 19Arf tumor suppressor proteins via Bmi-1 enhances 
stem cell self-renewal but has little effect on neural progenitor proliferation (Molofsky eta/., 
2003). 
There has been some evidence suggesting that Mcl-1 expression levels are influenced by 
trophic factors including insulin-like growth factor I (Zhang & D'Ercole, 2004). As trophic 
factor administration has been identified as a mechanism to expand the adult NPC population 
(Reynolds & Weiss, 1992; Craig eta/., 1996), Mcl-1 gain-of-function strategies may offer a 
potential additive effect to trophic factor expansion by reducing the endogenous rate of apoptosis 
that occurs within this population. One advantage of this approach lies with current techniques 
such as retroviral gene delivery that can be used in the experimental setting to allow Mel- I gain-
of-function to be maintained during proliferation, migration and differentiation, which could 
dramatically enhance the regenerative capacity of adult NPCs. 
One ofthe major drawbacks that our Mcl-1 gain-of-function study has, is that it does not 
address whether Mcl-1 gain-of-function selectively rescues a particular subpopulation of the 
neural precursor population. There was an overall decrease in apoptosis in the Mcl-1 gain-of-
function study, but whether Mcl-1 gain-of-function selectively rescues NSCs over neural 
progenitor cells, or vice versa could have different effects. For instance, ifMcl-1 gain-of-
function selectively rescues NSCs, there would presumably be more NSCs proliferating, thus the 
entire NPC population would expand. However, if Mcl-1 gain-of-function selective ly rescues the 
neural progenitor population that are already committed to a neuronal fate, then Mcl-1 gain-of-
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function could result in an increase in neurogenesis without altering the NPC population. To 
specifically assess how Mel- I gain-of-function affects the adult neural stem cell population, a 
self-renewal assay (Reynolds & Weiss, 1992) could be performed on SVZ-derived NPCs that are 
infected with a Mel- I expressing lentiviral construct that integrates into the host genome. By 
using a construct that stably integrates into the host genome, Mel- I gain-of-function would be 
maintained in all progeny and would thus avoid the dilution effect that would be seen using DNA 
plasmid constructs. If Mcl-1 gain-of-function enhanced NSC survival without altering cell cycle 
kinetics, then the self-renewal assay should yield a higher number of secondary neurospheres 
demonstrating an expansion of the neural stem cell population. 
To specifically assess how Mel- I gain-of-function affects the neural progenitor 
population, one could use both in vitro and in vivo strategies. More specifically, if the spheres 
formed in an in vitro neurosphere assay were much larger as compared to controls, this would 
also suggest that more progenitors are surviving demonstrating that Mel- I gain-of-function 
affects the neural progenitors in vitro. Furthermore, to assess how Mel-! gain-of-function affects 
neural progenitors in vivo, one could overexpress Mel- I through in vivo electroporation, as over 
99% of the SVZ proliferating population are neural progenitors (Craig eta!. , 1994; Morshead et 
a!., 1994). To specifically address whether Mel- I gain-of-function enhances the survival of 
NPCs in vivo is very challenging, as many ofthe techniques used to measure survival also 
measure proliferation. For instance, the I 0.5hrs BrdU labelling protocol could be used to address 
whether Mcl-1 gain-of-function leads to an expansion of the neural progenitor population. 
However, if there was an increased number ofBrdU+ cells in the Mel- I gain-of-function group, 
an equally strong argument could be made for either survival or proliferation. Although both 
arguments are legitimate, increasing either survival and/or proliferation would lead to an 
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expansion of the neural precursor population, which could have a putative therapeutic role. 
However, one way to differentiate between proliferation and survival in a potential NPC 
expansion would be to do Mcl-1 gain-of-function transfection experiments in a Bax knockout. 
By eliminating the pro-apoptotic affects of Bax, there should be no difference in the level of 
apoptosis in Mcl-1 gain-of-function group and controls. Therefore, any difference in the number 
of transfected cells would be the result of altered proliferation and not survival. Conversely, if 
there was no difference in the proliferation of Mcl-1 vs. control transfected cells, th is would 
suggest that the NPC expansion that is seen is due to survival and not proliferation. 
Future Directions 
Collectively, the results of this thesis demonstrate that Mcl-1 is a critical survival factor 
for adult NPCs. This has a number of implications for both the healthy aging brain as well as the 
injured brain. Firstly Tropepe eta/. , ( 1997) have shown that there is a decline in neural 
progenitors in the SVZ of aging animals and that this is a result of a lengthening ofthe cell cycle 
within this population. This presents a major problem when targeting adult NPCs for the 
treatment of different neurodegenerative diseases, as many of these are more prevalent in the 
aging brain. One way to remedy this situation would be to enhance the expres ion ofMcl-1 in 
TACs, which would presumably decrease the endogenous rate of apoptosis in the TAC 
population. Moreover, by enhancing the survival ofNPCs in vivo, the cells that were rescued 
could also contribute to the SVZ niche, which would further support the maintenance of the 
neural precursor population throughout the life time (Riquelme, et al. , 2008). In summary, Mcl-1 
gain-of-function in NPCs of the aging healthy brain may offer several key benefits that would 
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allow the NPC population to be poised to offer an enhanced regenerative re ponse when a 
neurodegenerative in ult occurs. 
There have been many studies demonstrating that endogenous PCs respond to stroke in 
a potentially therapeutic manner (for review ee Lindval l & Kokaia, 201 0). Furthermore, this 
therapeutic re ponse can be enhanced by applying trophic factors that promote proliferation and 
ubsequently applying factors that direct differentiation toward a neuronal fate (Kolb eta!., 
2007). However, one of the greatest challenges that exists w ithin this area of research is the high 
rate of cell death that occurs in these newly born cel l (Lindvall & Kokaia, 20 I 0). To combat this 
problem, one approach cou ld involve genetic manipulation of the PC population such that they 
are resistant to apoptosi after migrating away from the SVZ niche. T he Mcl-1 gain-of-function 
experiment completed in this thes is suggests that Mcl-1 would be a good target to enhance the 
survival of endogenous NPCs that migrate away from the SVZ when responding to an injury 
uch as a stroke. 
0 A expression pia mids were u ed to alter the genetic makeup of adult P in all of 
the experiments carried out in this thesis. This type of genetic manipulation i beneficial for 
short-term experiment that do not involve multiple cell divisions. To fully assess how Mcl-1 
gain-of-function affect both the aging healthy brain as well as the injured brain, one would need 
to stably insert a copy of the Mcl-1 gene driven off a constitutively active promoter into the PC 
genome so that Mc l-1 gain-of-function would be carried forward during proliferation. Th is could 
be accomplished by us ing a retrovirus and such a strategy would be suffic ient for proof-of-
principle Mcl-1 gain-of-function studies. Obviously, the ultimate goal when applying Mcl-1 
gain-of-function to any disease model would be to achieve recovery of function. However, 
because any study that employed a retrovirus cou ld only enhance Mcl-1 expres ion in a 
--------- -
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proportion of the NPC population, it is reasonable to suggest that this type of approach would not 
provide the full benefit Mcl-1 gain-of-function has to offer. To achieve the optimal benefit that 
Mcl-1 gain-of-function offers would require an inducible transgenic mouse that drives Mcl-1 off 
of the Nestin promoter. Once induced, Mcl-1 gain-of-function would be present within the entire 
neural precursor population as well as all of the subsequent NPC progeny. This would provide 
the optimal setting to assess whether Mcl-1 gain-of-function leads to functional recovery in a 
variety of neurodegenerative diseases. 
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